Company news

Arecor Therapeutics PLC news in 2024

Arecor Therapeutics PLC's news releases, calls and decks from 2024, newest first.

View company

Arecor Signs Exclusive Licensing Agreement

December 30, 2024

Arecor Appoints Interim Chief Financial Officer

November 18, 2024

Interim Results for six months ended 30 June 2024

September 26, 2024

Arecor presents positive AT278 data at EASD

September 11, 2024

Arecor announces AT278 presentation at EASD 2024

September 3, 2024

Result of General Meeting and Total Voting Rights

August 8, 2024

Posting of Circular and General Meeting

July 23, 2024

Result of WRAP Retail Offer

July 23, 2024

Result of Placing and Subscription

July 19, 2024

WRAP Retail Offer to raise up to £1 million

July 19, 2024

Proposed Placing and Subscription

July 19, 2024

Trading and Funding Update

June 10, 2024

Posting of 2023 Annual Report and Notice of AGM

May 31, 2024

Arecor to host company and KOL webinar today

May 21, 2024

Positive headline results for AT278 clinical trial

May 20, 2024

Final results for 2023

May 16, 2024

Arecor and Medtronic Diabetes collaboration

May 9, 2024

Publication of Full Year Financial Results delayed

May 3, 2024

Notice of results

April 29, 2024

Board change

April 23, 2024

Arecor and TRx Biosciences research collaboration

March 12, 2024

Arecor announces launch of Ogluo® in Netherlands

February 29, 2024

Year End Trading Update

February 1, 2024

Arecor announces update on INBRX-101

January 23, 2024

Arecor granted key European patent

January 18, 2024

Expansion of specialty hospital collaboration

January 8, 2024

Appointment of SVP for Tetris Pharma Ltd

January 3, 2024

Calls in 2024

Decks in 2024